COVID-19'U ANLAMAK: SİTOKİN ETKİSİNİN İMMÜNOPATOJENİK MEKANİZMALARI
Open Access
- 30 December 2021
- journal article
- review article
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 28 (4) , 687-694
Abstract
Cytokine release syndrome (CRS) or cytokine storm is as a result of the excess production of pro-inflammatory cytokines which is due to the disproportionate response of the immune system which can be instigated by SARS-CoV-2. COVID-19 which is caused by SARSCoV- 2 has a correlation with cytokines. SARSCoV- 2 instigates the production of IL-1 by ubiquitous macrophages and mast cells. IL-1 tends to influence the production of IL-6 and TNF-α. The progression of COVID-19 severity influences the level of certain cytokines such as IL-6. IL-6 is the cytokine chiefly responsible for the occurrence of CRS. CRS is the cause of COVID-19-related complications and the main cause of COVID-19-related deaths. Despite the data reported in the literature so far, the relationship between SARS-CoV-2 and cytokines has not been fully elucidated. The aim of the present review is to examine the relationship in question. Targeting cytokines during COVID-19 treatment has the potential to increase patient survival and reduce COVID-19-related deaths. It is concluded that focusing on the mechanisms of cytokine release and the effects of released cytokines, especially examining the effects on T lymphocytes and IFN-γ production in COVID-19 disease, may help reduce the lethal effects of the disease.Keywords
Funding Information
- Çalışmada herhangi bir destek alınmamıştır.
This publication has 43 references indexed in Scilit:
- Thermal stability of cytokines: A reviewCytokine, 2020
- Cytokines in clinical cancer immunotherapyBritish Journal of Cancer, 2018
- Cytokine release syndromeJournal for ImmunoTherapy of Cancer, 2018
- Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine EraArthritis & Rheumatology, 2017
- Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and LimitationsInternational Journal of Cell Biology, 2016
- Interleukin-6 (IL-6) and IL-17 Synergistically Promote Viral Persistence by Inhibiting Cellular Apoptosis and Cytotoxic T Cell FunctionJournal of Virology, 2014
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012
- IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human CellsThe Journal of Immunology, 2011
- Role of the IL-6 Classic- and Trans-Signaling Pathways in Corneal Sterile Inflammation and Wound HealingInvestigative Ophthalmology & Visual Science, 2011
- Proinflammatory CytokinesChest, 2000